4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000919574-20-000567
Director acquired 8,000,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-01-22 | Conversion : show line 1 in the form | +5,000,000 | 25,683,233 | D |
| 2020-01-24 | Conversion : show line 2 in the form | +3,000,000 | 28,683,233 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-01-22 | Conversion : show line 3 in the form Series B Convertible Preferred Stock | −1,000,000 | 5,000,000 | 1,857,143 | D |
| 2020-01-24 | Conversion : show line 4 in the form Series B Convertible Preferred Stock | −600,000 | 3,000,000 | 1,257,143 | D |
Loading xslF345X03/ownership.xml…